Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ann-Charlott Schneider"'
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Pathological corneal hem- and lymphangiogenesis are prime risk factors for corneal graft rejection. Fine needle-diathermy (FND) is an option to regress corneal blood vessels; however, whether this treatment besides clinically visible blood vessels al
Autor:
Felix Bock, Viet Nhat Hung Le, Yanhong Hou, Thomas Clahsen, Claus Cursiefen, Ann-Charlott Schneider
Publikováno v:
Investigative Opthalmology & Visual Science
Purpose Pathologic corneal (lymph) angiogenesis is a known risk factor for immune-mediated allograft rejections after corneal transplantation. However, there is no established treatment to regress pre-existing pathological corneal blood and lymphatic
Autor:
Yanlong Bi, Ann-Charlott Schneider, Deniz Hos, Claus Cursiefen, Gabriele Braun, Björn Bachmann, Felix Bock, Jasmine Onderka
Publikováno v:
Investigative ophthalmologyvisual science. 57(15)
Purpose The avascular cornea is in direct contact with aqueous humor (AqH). Here we investigate whether AqH exerts anti(lymph)angiogenic effects and thereby may contribute to corneal (lymph)angiogenic privilege. Methods Using the murine model of sutu
Autor:
Thomas Reinhard, Johanna M. Walz, Bertan Cakir, Hansjürgen Agostini, Anima Bühler, Andreas Stahl, Clemens Lange, Günther Schlunck, Felix Bock, Tristan Reuer, Thabo Lapp, Ann-Charlott Schneider, Claus Cursiefen
Publikováno v:
Investigative Opthalmology & Visual Science. 59:5277
Purpose Corneal vascularization significantly increases the risk for graft rejection after keratoplasty. Semaphorin 3F (Sema3F) is a known modulator of physiologic avascularity in the outer retina. The aim of this study was to investigate whether Sem
Autor:
Maulik Vyas, Hinrich P. Hansen, Michael Hallek, Ann-Charlott Schneider, Elke Pogge von Strandmann, Ulrike Köhl, Samir Tawadros, Stephan Kloess, Olga Shatnyeva, Katrin S. Reiners
Publikováno v:
OncoImmunology. 5:e1211220
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia that affects B lymphocytes in adults. Natural killer (NK) cells in CLL patients are intrinsically potent but display poor in situ effector functions. NKG2D is an activating recept